L-NMMA's Effect on Renal and Cardiovascular Variables in Healthy Subjects. A Randomized, Placebo-controlled Crossover Study.
Phase of Trial: Phase I
Latest Information Update: 18 Feb 2011
At a glance
- Drugs Tilarginine (Primary)
- Indications Cardiogenic shock; Myocardial infarction
- Focus Pharmacodynamics
- 24 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2010 New trial record